Melatonin: A potential nighttime guardian against Alzheimer's

Z Zhang, P Xue, BB Bendlin, H Zetterberg… - Molecular …, 2024 - nature.com
In the context of the escalating global health challenge posed by Alzheimer's disease (AD),
this comprehensive review considers the potential of melatonin in both preventive and …

Role of melatonin in Alzheimer's disease: from preclinical studies to novel melatonin-based therapies

J Roy, KY Wong, L Aquili, MS Uddin, BC Heng… - Frontiers in …, 2022 - Elsevier
Melatonin and novel melatonin-based therapies such as melatonin-containing hybrid
molecules, melatonin analogues, and melatonin derivatives have been investigated as …

Melatonin: a neurotrophic factor?

A Miranda-Riestra, R Estrada-Reyes… - Molecules, 2022 - mdpi.com
Melatonin, N-acetyl-5-hydroxytryptamine, is a hormone that synchronizes the internal
environment with the photoperiod. It is synthesized in the pineal gland and greatly depends …

[HTML][HTML] Melatonin reduces β-amyloid accumulation and improves short-term memory in streptozotocin-induced sporadic Alzheimer's disease model

MK Andrade, LC Souza, EM Azevedo, EL Bail… - IBRO Neuroscience …, 2023 - Elsevier
Melatonin is a hormone secreted by the pineal gland, it can be associated with circadian
rhythms, aging and neuroprotection. Melatonin levels are decreased in sporadic Alzheimer's …

Protective Activity of Melatonin Combinations and Melatonin‐Based Hybrid Molecules in Neurodegenerative Diseases

F Galvani, M Cammarota, F Vacondio… - Journal of pineal …, 2024 - Wiley Online Library
The identification of protective agents for the treatment of neurodegenerative diseases is the
mainstay therapeutic goal to modify the disease course and arrest the irreversible disability …

Participation of Ca2+-Calmodulin–Dependent Protein Kinase II in the Antidepressant-Like Effects of Melatonin

A Miranda-Riestra, MG Cercós, C Trueta… - Molecular …, 2024 - Elsevier
ABSTRACT Melatonin (N-acetyl-5-methoxytryptamine) is an indoleamine secreted by the
pineal gland during the dark phase of the photoperiod. Its main function is the …

Melatonin in Alzheimer's Disease: Literature Review and Therapeutic Trials

MJ Steinbach, NL Denburg - Journal of Alzheimer's Disease, 2024 - journals.sagepub.com
There are currently no effective treatments to prevent, halt, or reverse Alzheimer's disease
(AD), the most common cause of dementia in older adults. Melatonin, a relatively harmless …

Protective Effect of the Novel Melatonin Analogue Containing Donepezil Fragment on Memory Impairment via MT/ERK/CREB Signaling in the Hippocampus in a Rat …

J Tchekalarova, P Ivanova, D Krushovlieva… - International Journal of …, 2024 - mdpi.com
A reduction in melatonin function contributes to the acceleration of Alzheimer's disease (AD),
and understanding the molecular processes of melatonin-related signaling is critical for …

Synthesis, in silico, and biological evaluation of a borinic tryptophan-derivative that induces melatonin-like amelioration of cognitive deficit in male rat

M Barrón-González, MC Rosales-Hernández… - International Journal of …, 2022 - mdpi.com
Preclinical and clinical evidence supports melatonin and its analogues as potential
treatment for diseases involving cognitive deficit such as Alzheimer's disease. In this work …

Integrated lipidomics and network pharmacology analysis of the protective effects and mechanism of Yuanzhi San on rats with cognitive impairment

J Wang, J Li, K Liu, S Wang, Q Su, Y Cheng… - Bioorganic & Medicinal …, 2022 - Elsevier
Cognitive impairment (CI) can seriously affect people's mental and physical health. Yuanzhi
San (YZS) is a classic prescription for treating CI, but the mechanisms need further …